Elevated Swelling-Activated Chloride Current Densities in Hypertrophied Ventricular Myocytes in a Rabbit Heart Failure Model
Background: The status of the swelling-activated chloride channel (ICl, swell) during heart failure remains unclear. This study aimed to investigate whether the ICl, swell activity is altered during heart failure and to determine how the ICl, swell influences atrial arrhythmias of the failing heart.
Methods: We established a heart failure rabbit model and analyzed the hemodynamic indicators 8 weeks after myocardial infarction, which include left ventricular systolic pressure (LVSP) and left ventricular end-diastolic pressure (LVDEP). Five untreated rabbits and 5 receiving a sham operation served as the control group. Left auricular appendage tissues were obtained and CLCN3 mRNA/CLCN3 protein expression levels were examined by using reverse transcription–polymerase chain reaction and Western blot, respectively.
Results: Compared to the control group, the heart failure group showed a significantly decreased LVSP (14.2 ± 0.27 versus 16.9 ± 0.86 kPa, P <.05)and elevated LVDEP (2.49 ± 0.30 versus 0.15 ± 0.03 kPa, P <.05), indicating that myocardial infarction leads to progressive heart failure of rabbits in the heart failure group. CLCN3 mRNA and CLCN3 protein expression were both significantly elevated in the heart failure group compared to the control group (P <.05).
Conclusion: In sum, we propose that the dynamic nature of ICl, swell upregulation may contribute to the elevated expression of CLCN3 mRNA and CLCN3 protein, resulting in myocardial cell remodeling induced by heart failure. However, further study is needed to investigate the potential functions of ICl, swell, especially the relation between ICl, swell augmentation and arrhythmia after heart failure.
Akar JG, Everett TH, Ho R, et al. 2003. Intracellular chloride accumulation and subcellular elemental distribution during atrial fibrillation. Circulation 107:1810-5.
Borsani G, Rugarli EI, Taglialatela M, Wong C, Ballabio A. 1995. Characterization of a human and murine gene (CLCN3) sharing similarities to voltage-gated chloride channels and to a yeast integral membrane protein. Genomics 27:131-41.
Clemo HF, Stambler BS, Baumgarten CM. 1998. Persistent activation of a swelling-activated cation current in ventricular myocytes from dogs with tachycardia-induced congestive heart failure. Circ Res 83:147-57.
Clemo HF, Stambler BS, Baumgarten CM. 1999. Swelling-activated chloride current is persistently activated in ventricular myocytes from dogs with tachycardia-induced congestive heart failure. Circ Res 84:157-65.
Demion M, Guinamard R, EI Chemaly AE, Rahmati M, Bois P. 2006. An outwardly rectifying chloride channel in human atrial cardiomyocytes. J Cardiovasc Electrophysiol 17:60-8.
Du XY, Sorota S. 1997. Cardiac swelling-induced chloride current depolarizes canine atrial myocytes. Am J Physiol 272(4 Pt 2):H1904-16.
Duan D, Fermini B, Nattel S. 1995. α-Adrenergic control of volume-regulated Cl– currents in rabbit atrial myocytes: characterization of a novel ionic regulatory mechanism. Circ Res 77:373-93.
Duan D, Liu LL, Wang GG, et al. 2004. Cell volume-regulated ion channels and ionic remodeling in hypertrophied mouse heart. J Card Fail 10(4 suppl):S72.
Duan DD. 2013. Phenomics of cardiac chloride channels. Compr Physiol 3:667-92.
Duan DY, Liu LL, Bozeat N, et al. 2005.Functional role of anion channels in cardiac diseases. Acta Pharmacol Sin 26:265-78.
Hiraoka M, Kawano S, Hirano Y, Furukawa T. 1998. Role of cardiac chloride currents in changes in action potential characteristics and arrhythmias. Cardiovasc Res 40:23-33.
Hume JR, Harvey RD. 1991. Chloride conductance pathways in heart. Am J Physiol 261(3 Pt 1):C399-412.
Jentsch TJ, Günther W, Pusch M, Schwappach B. 1995. Properties of voltage-gated chloride channels of the CLC gene family. J Physiol 482:19S-25S.
Kawasaki M, Uchida S, Monkawa T, et al. 1994. Cloning and expression of a protein kinase C-regulated chloride channel abundantly expressed in rat brain neuronal cells. Neuron 12:597-604.
Liu LL, Ye L, McGuckin C, Hatton WJ, Duan D. 2003. Disruption of Clcn3 gene in mice facilitates heart failure during pressure overload. J Gen Physiol 122:33A.
Pye MP, Black M, Cobbe SM. 1996. Comparison of in vivo and in vitro haemodynamic function in experimental heart failure: use of echocardiography. Cardiovasc Res 31:873-81.
Rouet-Benzineb P, Mohammadi K, Pérennec J, Poyard M, Bouanani NE, Crozatier B. 1996. Protein kinase C isoform expression in normal and failing rabbit hearts. Circ Res 79:153-61.
Schmidt C, Schwendenwein I, Wieselthaler G, et al. 1996. Pharmacologically induced heart failure for the evaluation of circulatory assistance. Artif Organs 20:685-8.
Wang J, Xu H, Sun X, Niu W. 2006. Pharmacological and biophysical properties of swelling-activated chloride channel in mouse cardiac myocytes. Chin J Physiol 49:126-31.
Wu JB, Xu CX, Zhang JC, Chen L, Lin LF, Hu XZ. 2005. [Study of chloride channel ClC-3 gene expression in patient with atrial fibrillation]. Chin J Clin Pharmacol Ther 10:651-4. Chinese.
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).